1. Contracts ending soon
  2. Food and Drug Administration
  3. NAICS 541714

Research and Development in Biotechnology (except Nanobiotechnology) contracts ending at Food and Drug Administration

Department of Health and Human Services

42 contracts of $100,000 or more under NAICS 541714, research and development in biotechnology (except nanobiotechnology), at Food and Drug Administration end in the next 18 months, with $121M obligated so far. 9 end within six months, so their follow-on may already be in the works.

Ending in 18 months
42 contracts$121M obligated so far
Biggest holder
Deloitte Consulting Llp$47.2M on 1 contract ending soon
Open notices
NAICS 541714contract opportunities open now
Source
USAspending.govUpdated Nov 17, 2026, 7:37 PM UTC

Contracts ending soon

Soonest end first. Each contract links to its record on USAspending.gov.

ContractObligatedEndsState
Veterinary Clinical and Technical Services for the White Oak Animal Program (Woap)Priority One Services, Inc. · 75F40126F19006$1,297,948Dec 29, 2026in 1 monthMD
Animal Care and Husbandry Services for the White Oak Animal Program (Woap)Priority One Services, Inc. · 75F40126F19007$1,285,606Dec 29, 2026in 1 monthMD
Administrative Support Services Animal Care and Vivarium Management for the White Oak Animal Program (Woap)Priority One Services, Inc. · 75F40126F19005$616,274Dec 29, 2026in 1 monthMD
This Is a Firm Fixed Price Fornew Plga Analytical Methods for Mini-Size Complex Long-Acting Injectable Formulations.Akina, Inc. · 75F40123C00192$1,211,682Dec 31, 2026in 1 monthIN
Comprehensive Real-World Evidence on Off-Label Ketamine Safety to Inform Regulatory and Clinical Decision MakingAmerican College of Emergency Physicians · 75F40124C00129$762,969Dec 31, 2026in 1 monthTX
Calibrating Rwe Studies in Oncology Against Randomized TrialsBrigham & Womens Hospital Inc · 75F40122C00181$3,700,000Jan 29, 2027in 2 monthsMD
FY23C1EWP5 Development of Neuroblastoma Tissue Diagnostic Utility Through Fusion of Deep Learning-Based Image Analytics and Targeted Multiplex ProteomicsThe Leland Stanford Junior University · 75F40123C00103$1,675,147Jan 30, 2027in 2 monthsCA
Eo 14398 - This Project Shall Sequence and Characterize the Genome of Bdbv in the Current Outbreak, With a Specific Target to Sequence and Analyze the Bdbv Genome From As Many As 1,000 PatientsUniversity of Liverpool · 75F40126C00106$349,995Feb 20, 2027in 3 monthsNot stated
Nctr on-Site Animal Care and Technical Procedures in Accordance With Pws and AppendicesThe Bionetics Corp · 75F40123C00099$15,305,870Feb 25, 2027in 3 monthsAR
Preventive Maintenance-Repair (Pm/R) Service for Instruments Listed on Attachment 1 to This to, Under Ordering Period 3 of the Contract. Period of Performance for This to Is 5/24/2026 - 5/23/2027Ab Sciex LLC · 75F40126F19003$262,095May 23, 2027in 6 monthsMD
Dpmwp 217/Cdrh-2022-112765 - Develop Standards for Data Quality and Data Sources That Increase the Quality, Interoperability, and Usability of Real-World Data.Deloitte Consulting Llp · 75F40122C00143$47,188,964Jun 9, 2027in 6 monthsMD
Design a Two-Stage Process for Using Rwe to Support Labeling Expansions for Effectiveness Claims That Is Aligned With Regulatory Requirements/Demonstrate and Empirically Test the Process With…Brigham & Womens Hospital Inc · 75F40122C00154$2,708,850Jun 27, 2027in 7 monthsMD
Fdabaa-24-00123, Ref # FY24C1EP6, Cardiovascular-Kidney-Metabolic (Ckm) Syndrome Patient-Reported Outcome (Pro) Burden MeasurePpd Development Lp · 75F40124C00117$724,461Jul 15, 2027in 7 monthsNC
Baa for Development of Drug Development Tools for AdtkdThe Critical Path Institute · 75F40124C00106$2,774,844Aug 21, 2027in 9 monthsAZ
Baa FY2600123 Developing Standardized Case Definition for Adverse EventsThe Task Force for Global Health, Inc. · 75F40126C00095$995,374Aug 31, 2027in 9 monthsGA
Baa No. FY25C1CP32: Quality and Safety of Botanical Products: Addressing Herb-Drug InteractionsThe University of Mississippi · 75F40125C00072$799,998Sep 21, 2027in 10 monthsMS
Baa No. FY25C1BP3 - Combining Machine Learning and Mechanistic Models to Create a Digital Framework for Rapidly Designing Continuous Bioprocess OperationsSimvantage Gmbh · 75F40125C00073$661,012Sep 21, 2027in 10 monthsMD
Eo 14398 Baa Identification and Performance Assessment of Medical Devices in Electronic Health Record Data Development of a Transparent and Repeatable Framework to Enhance Medical Device Integration…Rutgers the State University of New Jersey · 75F40126C00065$6,515,098Sep 23, 2027in 10 monthsNJ
To Characterize the Clinical Presentation of C-Vam/to Contrast C-Vam With Cardiac Complications of Infection With Sars-Cov-2 That the Immunization Seeks to Prevent/to Inform Best Practices for…New York Medical College · 75F40122C00148$2,573,556Sep 27, 2027in 10 monthsMD
Continuous Drug Substance Manufacturing From Biomass-Derived Building Blocks Baa Pmqwp #356.National Institute for Pharmaceutical Technology & Education Inc · 75F40122C00192$3,000,000Sep 28, 2027in 10 monthsMD
Alp# 125378 - Barda Idiq 75A50123D00004 FDA Single Award Task Order 75A50123F61003President and Fellows of Harvard College · 75F40124F19004$4,706,084Sep 29, 2027in 10 monthsMA
Research Challenges Related to Environmentally Friendly Propellants in Metered Dose InhalersAptargroup Inc · 75F40123C00186$3,371,449Sep 29, 2027in 10 monthsIL
A Mosaic Approach for Understanding Stimulant and Opioid Use and Use Disorder Trajectories and Associated Consequences in US AdultsRegents of the University of Michigan · 75F40124C00131$1,649,006Sep 29, 2027in 10 monthsMI
Ddi Clinical Pharmacology StudyTranquil Clinical and Research Consulting Services LLC · 75F40126F19005$1,592,481Sep 29, 2027in 10 monthsTX
Baa FY26C3AP4: a Cross-Species Immune Organ Chip Reference Framework for Regulatory Evaluation of Vaccine and Antiviral Medical Countermeasures = Eo 14398Board of Regents of Nevada System of Higher Education · 75F40126C00083$1,500,000Sep 29, 2027in 10 monthsNV
Sunscreen Absorption Clinical Pharmacology StudyTranquil Clinical and Research Consulting Services LLC · 75F40126F19004$1,294,478Sep 29, 2027in 10 monthsTX
Assessing the Effectiveness of Text Enhancements to Prevent Drug Name Confusion ErrorsNorthwestern University · 75F40122C00191$1,184,888Sep 29, 2027in 10 monthsMD
FDA Baa FY26C1CP13 3-Year Firm-Fixed Price (Ffp) Contract for Investigating the Impact of Diastereomers and Synthesis-Related Impurities on the Immunogenicity of Oligonucleotides.University of Connecticut · 75F40126C00087$1,173,033Sep 29, 2027in 10 monthsCT
Impact of Api Cqas on in Situ Forming Implants and Understanding in Vitro and in Vivo Performance DifferencesUniversity of Connecticut · 75F40123C00142$1,103,886Sep 29, 2027in 10 monthsCT
Baa# FY25C1BP27 - Development and Implementation of Ai/Ml Toolbox for Digitalization of Advanced Modular Continuous Api Manufacturing ProcessRutgers, the State University · 75F40125C00089$999,347Sep 29, 2027in 10 monthsNJ
Baa Contract- FY26C2AP9 Advanced Cmc Index and Intelligence Platform for Drug Quality Control, Shortage Prediction, and Strategic ReshoringNational Institute for Pharmaceutical Technology & Education Inc · 75F40126C00069$634,642Sep 29, 2027in 10 monthsMN
In Vitro Tests to Support Bioequivalence Determination When Generic Dermatological Formulation Has Differences From the Brand Product FormulationThe Corporation of Mercer University · 75F40123C00204$507,265Sep 29, 2027in 10 monthsGA
The Overarching Objective Is to Establish a Quantitative in Vitro in Vivo Extrapolation Framework Capable of Predicting the Influence of Formulation Composition, Digestion Behavior, Chylomicron…Simulations Plus Inc · 75F40126C00063$575,554Dec 29, 2027in 13 monthsMD
Eo 14398-Broad Agency Announcement (Baa) Contract for Modernizing Outcome Data for Opioid Use Disorder (Mod-Oud)Digital Medicine Society Inc · 75F40126C00158$948,781Dec 30, 2027in 13 monthsMA
To Develop and Conduct 3D Correlative Imaging, Quantitative Ai-Based Analysis of Critical Quality Attributes (Cqas), and Perform Image- Based in Silico Release Modelling, Using Model Long-Acting…Digim Solution LLC · 75F40126F19003$500,635Feb 28, 2028in 15 monthsMD
Baa Benefit-Transfer Methods on Diabetes Medical Devices FY24C1IP2 DpcdDuke University · 75F40124C00083$699,087Mar 12, 2028in 15 monthsNC
Harness Diverse Data Through Information Sciences to Improve Health Outcome/ Evaluate Bias, Recruitment, and Retention in an Online Setting/ Recruitment and Retention Optimization Study/ Content…Denver Health and Hospital Authority · 75F40122C00165$1,353,024Mar 27, 2028in 16 monthsMD
Ffp Task Order for Proton Pump Inhibitor Pk Study for the Fda's Center for Drug Evaluation and Research (Cder), Office of Generic Drugs (Ogd).Tranquil Clinical and Research Consulting Services LLC · 75F40126F19001$1,227,674Mar 29, 2028in 16 monthsMD
The Food and Drug Administration?s Center for Biologics Evaluation and Research (Cber) Biologics Effectiveness and Safety Innovative Methods (Best Im) Program Enhances the Safety of Vaccines, Blood…The Johns Hopkins University · 75F40125C00054$517,607Mar 29, 2028in 16 monthsMD
Baa FY26C1CP48: a Multi-Agent Ai System for High-Throughput Pbpk Modeling: Predicting Formulation Effect on Drug Absorption and Human PharmacokineticsUniversity of California, San Francisco · 75F40126C00107$500,000Mar 29, 2028in 16 monthsCA
Eo 14398 Human Hindbrain OrganoidsOrganotherapeutics Gmbh · 75F40126P00334$253,868Mar 29, 2028in 16 monthsNot stated
The Food and Drug Administration (FDA) Is Responsible for Protecting the Public Health by Assuring the Safety, Efficacy, and Security of Human and Veterinary Drugs, Biological Products, Medical…Duke University · 75F40125C00053$749,661Mar 31, 2028in 16 monthsNC

End dates are the current period of performance; options not yet exercised can extend them. An ending contract may be competed again, extended, or moved to another vehicle. BPA calls and orders shorter than six months are left out. Department of Defense contracts appear on USAspending.gov about 90 days after award.

Get new notices under NAICS 541714

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy